A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes

Addictive Behaviors

Volumn 63, Issue , 2016, Pages 114-119

  Blevins, Claire E ^a   Banes, Kelsey E ^a   Stephens, Robert S ^a   Walker, Denise D ^b   Roffman, Roger A ^b  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Adolescents; Cannabis treatment; Synthetic cannabinoids

Indexed keywords

ALCOHOL; CANNABINOID; CANNABIS; STREET DRUG;

ADOLESCENT; ALCOHOL CONSUMPTION; ARTICLE; CANNABIS USE; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; HIGH SCHOOL STUDENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; SMOKING; TREATMENT OUTCOME; ADOLESCENT BEHAVIOR; ADULT; CANNABIS ADDICTION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK; STATISTICS AND NUMERICAL DATA; WASHINGTON; YOUNG ADULT;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADULT; CANNABINOIDS; DRUG USERS; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; RISK; STREET DRUGS; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; WASHINGTON; YOUNG ADULT;

EID: 84978828834     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2016.07.005     Document Type: Article

References (20)

1. Castellanos, D., Singh, S., Thornton, G., Avila, M., Moreno, A., Synthetic cannabinoid use: A case series of adolescents. The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine 49 (2011), 347–349, 10.1016/j.jadohealth.2011.08.002.
2. Dennis, M.L., Titus, J.C., White, M., Unsicker, J., Hodgkins, D., Global Appraisal of Individual Needs (GAIN): Administration guide for the GAIN and related measures(version 5). 2003, Chestnut Health Systems, Bloomington, IL.
3. Dennis, M.L., Funk, R., Godley, S.H., Godley, M.D., Waldron, H., Cross-validation of the alcohol and cannabis use measures in the Global Appraisal of Individual Needs (GAIN) 113 and Timeline Followback (TLFB; Form 90) among adolescents in substance abuse treatment. Addiction 99:Suppl. 2 (2004), 120–128.
4. Dresen, S., Ferreirós, N., Pütz, M., Westphal, F., Zimmermann, R., Auwärter, V., Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. Journal of Mass Spectrometry: JMS 45 (2010), 1186–1194, 10.1002/jms.1811.
5. Drug Enforcement Administration, Schedules of controlled substances: Temporary placement of five synthetic cannabinoids into schedule I. Federal Register, 76, 2011.
6. European Monitoring Center for Drugs and Drug Addiction, European Drug Report 2015. 2015, European Monitoring of Drugs and Drugs Addiction, Lisbon, Portugal, 10.2810/88175.
7. Every-Palmer, S., Synthetic cannabinoid JWH-018 and psychosis: An explorative study. Drug and Alcohol Dependence 117 (2011), 152–157, 10.1016/j.drugalcdep.2011.01.012.
8. Harris, C.R., Brown, A., Synthetic cannabinoid intoxication: A case series and review. The Journal of Emergency Medicine 44 (2013), 360–366, 10.1016/j.jemermed.2012.07.061.
9. IBM Corporation, IIBM SPSS Statistics for Windows, Version 21.0. 2012, IBM Corporation, Armonk, NY.
10. Johnson, V., White, H.R., The relationship between work-specific and generalized stress and alcohol and marijuana use among recent entrants to the labor force. Journal of Drug Issues 25 (1995), 237–251.
11. Johnston, L.D., O'Malley, P.M., Miech, R.A., Bachman, J.G., Schulenberg, J.E., Monitoring the Future national survey results on drug use: 1975–2014: Overview, key findings on adolescent drug use. 2015, MI, Ann Arbor.
12. Oluwabusi, O.O., Loback, L., Aktar, U., Youngman, B., Ambrosini, P.J., Synthetic cannabinoid-induced psychosis: Two adolescent cases. Journal of Child and Adolescent Psychopharmacology 22 (2012), 393–395.
13. Rosenbaum, C.D., Carreiro, S.P., Babu, K.M., Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. Journal of Medical Toxicology: Official Journal of the American College of Medical Toxicology 8 (2012), 15–32, 10.1007/s13181-011-0202-2.
14. Schafer, J., Brown, S.a., Marijuana and cocaine effect expectancies and drug use patterns. Journal of Consulting and Clinical Psychology 59 (1991), 558–565, 10.1037/0022-006X.59.4.558.
15. Simmons, J., Cookman, L., Kang, C., Skinner, C., Three cases of “spice” exposure. Clinical Toxicology (Philadelphia, Pa.) 49:5 (2011), 431–433, 10.3109/15563650.2011.584316.
16. Stogner, J.M., Miller, B.L., A spicy kind of high: A profile of synthetic cannabinoid users. Journal of Substance Use, 2014 Retrieved from http://www.tandfonline.com/doi/abs/10.3109/14659891.2013.770571.
17. Vandrey, R., Dunn, Fry, J.a., Girling, E.R., A survey study to characterize use of Spice products (synthetic cannabinoids). Drug and Alcohol Dependence 120 (2012), 238–241, 10.1016/j.drugalcdep.2011.07.011.
18. Walker, D.D., Stephens, R.S., Blevins, C.E., Banes, K.E., Matthews, L., Roffman, R.A., Augmenting brief interventions for adolescent marijuana users: The impact of motivational check-ins. Journal of Consulting and Clinical Psychology, 2016 (in press).
19. White, H.R., LaBouvie, E.W., Towards the assessment of alcohol problem drinking. Journal of Studies on Alcohol 50 (1989), 30–37.
20. Winstock, A.R., Barratt, M.J., Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug and Alcohol Dependence 131 (2013), 106–111, 10.1016/j.drugalcdep.2012.12.011.